EX-2.1
from 8-K
86 pages
Agreement and Plan of Merger Among: Tobira Therapeutics, Inc., a Delaware Corporation; Allergan Holdco US, Inc., a Delaware Corporation; and Sapphire Acquisition Corp., a Delaware Corporation Dated as of September 19, 2016
12/34/56
EX-2.1
from 8-K
80 pages
Agreement and Plan of Merger and Reorganization by and Among Regado Biosciences, Inc., Landmark Merger Sub Inc., Tobira Therapeutics, Inc. and With Respect to Section 5.14, Brent Ahrens, as Company Stockholders’ Agent Dated as of January 14, 2015
12/34/56
EX-2.1
from DEFA14A
80 pages
Agreement and Plan of Merger and Reorganization by and Among Regado Biosciences, Inc., Landmark Merger Sub Inc., Tobira Therapeutics, Inc. and With Respect to Section 5.14, Brent Ahrens, as Company Stockholders’ Agent Dated as of January 14, 2015
12/34/56
